Literature DB >> 28716959

Podocyte Growing Pains in Adaptive FSGS.

Vivette D D'Agati1.   

Abstract

Keywords:  FSGS; glomerular size; podocyte

Mesh:

Year:  2017        PMID: 28716959      PMCID: PMC5619978          DOI: 10.1681/ASN.2017060612

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  19 in total

Review 1.  Focal segmental glomerulosclerosis.

Authors:  Vivette D D'Agati; Frederick J Kaskel; Ronald J Falk
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

2.  Growth-dependent podocyte failure causes glomerulosclerosis.

Authors:  Akihiro Fukuda; Mahboob A Chowdhury; Madhusudan P Venkatareddy; Su Q Wang; Ryuzoh Nishizono; Tsukasa Suzuki; Larysa T Wickman; Jocelyn E Wiggins; Timothy Muchayi; Diane Fingar; Kerby A Shedden; Ken Inoki; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 10.121

3.  Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis.

Authors:  M Nagata; W Kriz
Journal:  Kidney Int       Date:  1992-07       Impact factor: 10.612

4.  Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis.

Authors:  Bart Smeets; Christoph Kuppe; Eva-Maria Sicking; Astrid Fuss; Peggy Jirak; Toin H van Kuppevelt; Karlhans Endlich; Jack F M Wetzels; Hermann-Josef Gröne; Jürgen Floege; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

Review 5.  A potential role for mechanical forces in the detachment of podocytes and the progression of CKD.

Authors:  Wilhelm Kriz; Kevin V Lemley
Journal:  J Am Soc Nephrol       Date:  2014-07-24       Impact factor: 10.121

6.  Sirolimus therapy of focal segmental glomerulosclerosis is associated with nephrotoxicity.

Authors:  Monique E Cho; John K Hurley; Jeffrey B Kopp
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

7.  Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis.

Authors:  Y Yoshida; A Fogo; I Ichikawa
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

Review 8.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

Review 9.  The challenge and response of podocytes to glomerular hypertension.

Authors:  Nicole Endlich; Karlhans Endlich
Journal:  Semin Nephrol       Date:  2012-07       Impact factor: 5.299

Review 10.  Podocyte mitosis - a catastrophe.

Authors:  L Lasagni; E Lazzeri; S J Shankland; H-J Anders; P Romagnani
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

View more
  4 in total

Review 1.  Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.

Authors:  An S De Vriese; Sanjeev Sethi; Karl A Nath; Richard J Glassock; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2018-01-10       Impact factor: 10.121

Review 2.  Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.

Authors:  Ke Sun; Qionghong Xie; Chuan-Ming Hao
Journal:  Kidney Dis (Basel)       Date:  2021-07-02

3.  Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling.

Authors:  Minglei Lu; Pei Wang; Yan Ge; Lance Dworkin; Andrew Brem; Zhangsuo Liu; Rujun Gong
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

4.  Critical timing of ACEi initiation prevents compensatory glomerular hypertrophy in the remaining single kidney.

Authors:  Abhijit S Naik; Su Q Wang; Mahboob Chowdhury; Jawad Aqeel; Christopher L O'Connor; Jocelyn E Wiggins; Markus Bitzer; Roger C Wiggins
Journal:  Sci Rep       Date:  2021-10-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.